The International Liver Congress 2014 / 49th Annual Meeting of the European Association for the Study of the Liver will feature an impressive array of scientific and educational content covering viral hepatitis, liver transplantation, and other topics in liver disease.
Combination Therapy with ABT-450/Ritonavir/Ombitasvir Is Highly Effective in Liver Transplant Patients with Hepatitis C
Is There Any Advantage to Treating Patients with Hepatitis C for Longer than 12 Weeks with Combination Sofosbuvir/Ledipasvir?
Encouraging Results from the ION-3 Study of Treatment-naÃ¯ve Patients with Hepatitis C without Cirrhosis
Combination Treatment with Sofosbuvir and Ledipasvir Gives Hope for Difficult-to-Treat Patients with Chronic Hepatitis C